Mrózek K - Articles from Medline

Last articles by author Mrózek K

110 articles found

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
02/07/2008
Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
19/06/2008
Patients With Acute Myeloid Leukemia and RAS Mutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
19/06/2008
Wilms Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study.
The New England journal of medicine
10/05/2008
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
Blood
02/07/2008
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
Blood
28/03/2008
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
14/09/2007
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
British Journal of Haematology
29/06/2007
Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
Blood
14/09/2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
Current Opinion in Hematology
21/03/2007
Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.

National Library of Medicine

Create email alert

Send to a friend

Doctors UK Consultants UK

Articles from other specialties:

Pulmonology, Anaesthesiology, Plastic Surgery, Neurology, Intensive Care, Oral and Maxillofacial Surgery, Clinical Analysis, Urology, Geriatrics, Clinical Neurophysiology, Cardiovascular Surgery, Vascular Surgery - Angiology, Paediatrics